193 related articles for article (PubMed ID: 27040796)
1. Blood-brain barrier transport kinetics of the neuromedin peptides NMU, NMN, NMB and NT.
Gevaert B; Wynendaele E; Stalmans S; Bracke N; D'Hondt M; Smolders I; van Eeckhaut A; De Spiegeleer B
Neuropharmacology; 2016 Aug; 107():460-470. PubMed ID: 27040796
[TBL] [Abstract][Full Text] [Related]
2. Effects of haloperidol, quinelorane, and lithium on regional neurotensin/neuromedin N concentrations: further evidence for neurotensin/neuromedin N-dopamine interactions.
Clement R; Griff D; Banks B; Nemeroff C; Kitabgi P; Bissette G
Synapse; 1994 Aug; 17(4):241-6. PubMed ID: 7992199
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of neurotensin/neuromedin N mRNA and products of NT/NMN precursor processing in neonatal rats.
Muraki K; Mitra SP; Dobner PR; Carraway RE
Peptides; 1993; 14(6):1095-102. PubMed ID: 8134290
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific processing of neurotensin/neuromedin-N precursor in cat.
Carraway RE; Mitra SP; Joyce TJ
Regul Pept; 1993 Jan; 43(1-2):97-106. PubMed ID: 8426913
[TBL] [Abstract][Full Text] [Related]
5. BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing.
Carraway RE; Mitra SP; Evers BM; Townsend CM
Regul Pept; 1994 Aug; 53(1):17-29. PubMed ID: 7800856
[TBL] [Abstract][Full Text] [Related]
6. The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior.
Botticelli L; Micioni Di Bonaventura E; Del Bello F; Giorgioni G; Piergentili A; Quaglia W; Bonifazi A; Cifani C; Micioni Di Bonaventura MV
Pharmacol Res; 2023 Sep; 195():106875. PubMed ID: 37517560
[TBL] [Abstract][Full Text] [Related]
7. Pro-Neurotensin/Neuromedin N and Risk of Cognitive Impairment in a Prospective Study.
Nicoli CD; Howard VJ; Judd SE; Struck J; Manly JJ; Cushman M
J Alzheimers Dis; 2020; 76(4):1403-1412. PubMed ID: 32623400
[TBL] [Abstract][Full Text] [Related]
8. Neuromedin U: a multifunctional neuropeptide with pleiotropic roles.
Martinez VG; O'Driscoll L
Clin Chem; 2015 Mar; 61(3):471-82. PubMed ID: 25605682
[TBL] [Abstract][Full Text] [Related]
9. Differential processing of neurotensin/neuromedin N precursor(s) in canine brain and intestine.
Carraway RE; Mitra SP
J Biol Chem; 1990 May; 265(15):8627-31. PubMed ID: 2341398
[TBL] [Abstract][Full Text] [Related]
10. Role of neurotensin receptor 1 in the regulation of food intake by neuromedins and neuromedin-related peptides.
Kim ER; Mizuno TM
Neurosci Lett; 2010 Jan; 468(1):64-7. PubMed ID: 19857548
[TBL] [Abstract][Full Text] [Related]
11. Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort.
Nicoli CD; Carson AP; Plante TB; Leann Long D; McClure LA; Schulte J; Cushman M
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3483-e3494. PubMed ID: 34013344
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier transport kinetics of the cyclic depsipeptide mycotoxins beauvericin and enniatins.
Taevernier L; Bracke N; Veryser L; Wynendaele E; Gevaert B; Peremans K; De Spiegeleer B
Toxicol Lett; 2016 Sep; 258():175-184. PubMed ID: 27349679
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of neuromedin U. I. Contractile activity of dog neuromedin U-related peptides on isolated chicken crop smooth muscle.
Sakura N; Kurosawa K; Hashimoto T
Chem Pharm Bull (Tokyo); 1995 Jul; 43(7):1148-53. PubMed ID: 7586058
[TBL] [Abstract][Full Text] [Related]
14. Compared binding properties of 125I-labeled analogues of neurotensin and neuromedin N in rat and mouse brain.
Gaudriault G; Zsürger N; Vincent JP
J Neurochem; 1994 Jan; 62(1):361-8. PubMed ID: 8263537
[TBL] [Abstract][Full Text] [Related]
15. Neuromedins NMU and NMS: An Updated Overview of Their Functions.
Malendowicz LK; Rucinski M
Front Endocrinol (Lausanne); 2021; 12():713961. PubMed ID: 34276571
[TBL] [Abstract][Full Text] [Related]
16. Differential processing of the neurotensin/neuromedin N precursor in the mouse.
Shaw C; McKay D; Johnston CF; Halton DW; Fairweather I; Kitabgi P; Buchanan KD
Peptides; 1990; 11(2):227-35. PubMed ID: 2356154
[TBL] [Abstract][Full Text] [Related]
17. Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo.
Stalmans S; Bracke N; Wynendaele E; Gevaert B; Peremans K; Burvenich C; Polis I; De Spiegeleer B
PLoS One; 2015; 10(10):e0139652. PubMed ID: 26465925
[TBL] [Abstract][Full Text] [Related]
18. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
19. The signaling signature of the neurotensin type 1 receptor with endogenous ligands.
Besserer-Offroy É; Brouillette RL; Lavenus S; Froehlich U; Brumwell A; Murza A; Longpré JM; Marsault É; Grandbois M; Sarret P; Leduc R
Eur J Pharmacol; 2017 Jun; 805():1-13. PubMed ID: 28341345
[TBL] [Abstract][Full Text] [Related]
20. Proneurotensin 1-117, a stable neurotensin precursor fragment identified in human circulation.
Ernst A; Hellmich S; Bergmann A
Peptides; 2006 Jul; 27(7):1787-93. PubMed ID: 16519961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
